Zobrazeno 1 - 10
of 204
pro vyhledávání: '"Limfomes"'
Autor:
Francesca Favaro, Demi Both, Ingrid A. M. Derks, Marcel Spaargaren, Cristina Muñoz-Pinedo, Eric Eldering
Publikováno v:
Oncogenesis, 12(1):6. Nature Publishing Group
Impairments in protein folding in the endoplasmic reticulum (ER) lead to a condition called ER stress, which can trigger apoptosis via the mitochondrial or the death receptor (extrinsic) pathway. There is controversy concerning involvement of the dea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::033c0b1669f432ff73dc2f2bcfddb811
https://doi.org/10.1038/s41389-023-00450-w
https://doi.org/10.1038/s41389-023-00450-w
Autor:
Ramón Diez-Feijóo, Concepción Fernández-Rodríguez, Marta Lafuente, Nieves García-Gisbert, Ana Ferrer, Luis Colomo, Marta Salido, Antonio Salar
Publikováno v:
Blood Advances. 7:162-166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc5c5e9971b9fd4946a0ba0aee8ef1d5
https://doi.org/10.1182/bloodadvances.2022008393
https://doi.org/10.1182/bloodadvances.2022008393
Autor:
Barbara Mankel, Colleen Ramsower, Leonie Frauenfeld, Franziska Otto, Itziar Salaverria, Falko Fend, Magda Pinyol, Natalia Castrejon-de-Anta, Olga Balagué, Julia Salmeron-Villalobos, Annika Katharina Mayer, Elias Campo, Lisa M. Rimsza, Sebastian Streich, Julia Steinhilber, Joan Enric Ramis-Zaldivar, Leticia Quintanilla-Martinez, Irina Bonzheim
Publikováno v:
Blood Advances. 6:2361-2372
Diffuse large B-cell lymphoma (DLBCL) with aberrant coexpression of CD10+BCL6+MUM1+ (DLBCL-AE), classified as germinal center B cell (GCB) type by the Hans algorithm (HA), was genetically characterized. To capture the complexity of DLBCL-AE, we used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55da3e40e1e267d1bb538d19c78ef095
https://doi.org/10.1182/bloodadvances.2021006034
https://doi.org/10.1182/bloodadvances.2021006034
Autor:
Pier Luigi Zinzani, Anna Sureda, Cecilia Carpio, Krimo Bouabdallah, Robin Meng, Guillaume Cartron, Marjolein van der Poel, Su-Peng Yeh, Raul Cordoba, Alessandro Re, Armando López-Guillermo, Lucie Lepine, Youngil Koh, Steven Le Gouill, Giovanni Abbadessa, Luís Francisco Araújo, Vincent Ribrag, Martine E D Chamuleau, Olivier Casasnovas, Ran Ji, Rao Saleem, Won Seog Kim, Maria Ilidia Moreira, Daniela Alves, Carmelo Carlo-Stella
Publikováno v:
Hematological Oncology, 41(1), 108-119. Wiley
Scientia
Carlo-Stella, C, Zinzani, P L, Sureda, A, Araújo, L, Casasnovas, O, Carpio, C, Yeh, S-P, Bouabdallah, K, Cartron, G, Kim, W S, Cordoba, R, Koh, Y, Re, A, Alves, D, Chamuleau, M, le Gouill, S, López-Guillermo, A, Moreira, I, van der Poel, M W M, Abbadessa, G, Meng, R, Ji, R, Lépine, L, Saleem, R & Ribrag, V 2022, ' A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma ', Hematological Oncology . https://doi.org/10.1002/hon.3089
Hematological Oncology. John Wiley and Sons Ltd
Scientia
Carlo-Stella, C, Zinzani, P L, Sureda, A, Araújo, L, Casasnovas, O, Carpio, C, Yeh, S-P, Bouabdallah, K, Cartron, G, Kim, W S, Cordoba, R, Koh, Y, Re, A, Alves, D, Chamuleau, M, le Gouill, S, López-Guillermo, A, Moreira, I, van der Poel, M W M, Abbadessa, G, Meng, R, Ji, R, Lépine, L, Saleem, R & Ribrag, V 2022, ' A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma ', Hematological Oncology . https://doi.org/10.1002/hon.3089
Hematological Oncology. John Wiley and Sons Ltd
Introduction: Immune checkpoint blockade of programmed death-1 (PD-1) receptor and its ligand (PD-L1) has contributed to efficacy in many tumor types, with clinical responses observed in a proportion of patients (pts) with Hodgkin lymphoma and rare n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086237dc28c03b5f031a7a993d237717
https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84
https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84
Autor:
Guerra, Ivan, Bujanda, Luis, Mañosa, Miriam, Pérez Martínez, Isabel, Casanova, María José, Peña, Luisa de la, Benito, Marina de, Rivero, Montserrat, Varela, Pilar, Bernal, Lorena, Franco, Ana Carolina, Ber, Yolanda, Piqueras, Marta, Tardillo, Carlos, Ponferrada, Ángel, Olivares, Sonsoles, Lucendo, Alfredo J., Gilabert, Pau, Sierra Ausín, Mónica, Bellart, María, Herrarte, Amaia, Calafat, Margalida, Francisco, Ruth de, Gisbert, Javier P., Guardiola, Jordi, Domènech, Eugeni, Bermejo, Fernando, The ENEIDA project of GETECCU
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 750
Volume 15
Issue 3
Pages: 750
Simple Summary An increased risk of hematological malignancies, mainly lymphomas, has been described in patients with inflammatory bowel disease (IBD). Because there are scarce data about the management and evolution of lymphomas in patients with IBD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05986ee675e10f319d35f60db6c90f1
Autor:
M Lia Palomba, Paola Ghione, Anik R Patel, Myrna Nahas, Sara Beygi, Anthony J Hatswell, Steve Kanters, Eve H. Limbrick-Oldfield, Sally W Wade, Markqayne D Ray, Jessica Owen, Sattva S Neelapu, John Gribben, John Radford, Sabela Bobillo
Publikováno v:
Palomba, M L, Ghione, P, Patel, A R, Nahas, M, Beygi, S, Hatswell, A J, Kanters, S, Limbrick-Oldfield, E H, Wade, S W, Ray, M D, Owen, J, Neelapu, S S, Gribben, J, Radford, J & Bobillo, S 2023, ' A 24-month updated analysis of the comparative effectiveness of ZUMA-5 (axi-cel) vs. SCHOLAR-5 external control in relapsed/refractory follicular lymphoma ', Expert Review of Anticancer Therapy, vol. 23, no. 2, pp. 199-206 . https://doi.org/10.1080/14737140.2023.2171994
Scientia
Scientia
Follicular lymphoma; Axicabtagene ciloleucel; Comparative effectiveness Limfoma fol·licular; Axicabtagene ciloleucel; Eficàcia comparativa Linfoma folicular; Axicabtagene ciloleucel; Eficacia comparativa Background In the ZUMA-5 trial (Clinical tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5d727090bb434c68e1185c778daaf38
Autor:
Beatriz Rey-Búa, Mónica Cabrero, Leyre Bento, Juan Montoro, Mariana Bastos-Oreiro, Rocío Parody, Lucrecia Yañez, Oriana Lopez-Godino, Joud Zanabili, Pilar Herrera, Gonzalo Gutierrez, Ariadna Perez, Jose L. Piñana, Silvana Novelli, María Cortés, Ana Maria Sureda, Dolores Caballero, Alejandro Martín García-Sancho
Publikováno v:
Cancers; Volume 14; Issue 22; Pages: 5670
Cancers (Basel), 2022, 14(22), 5670
Cancers (Basel), 2022, 14(22), 5670
Simple Summary Follicular lymphoma (FL) is the most prevalent subtype of indolent lymphoma, accounting for 70% of all cases. The estimated risk of histological transformation (tFL), such as diffuse large B cell lymphoma (DLBCL), varies from 2-3% per
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba7546b4795ce93fe3db126a910d0a43
http://hdl.handle.net/2445/191784
http://hdl.handle.net/2445/191784
Autor:
Marta Dafne Cabañero-Navalon, Victor Garcia-Bustos, Maria Nuñez-Beltran, Pascual Císcar Fernández, Lourdes Mateu, Xavier Solanich, Juan Luis Carrillo-Linares, Ángel Robles-Marhuenda, Francesc Puchades-Gimeno, Ana Pelaez Ballesta, Nuria López-Osle, Miguel Ángel Torralba-Cabeza, Ana María Bielsa Masdeu, Jorge Diego Gil, Nuria Tornador Gaya, Guillem Pascual Castellanos, Rosario Sánchez-Martínez, José Manuel Barragán-Casas, Andrés González-García, José Luís Patier de la Peña, Daniel López-Wolf, Antonia Mora Rufete, Alba Canovas Mora, Maria José Forner Giner, Pedro Moral Moral
Common variable immunodeficiency (CVID) constitutes a heterogenic group of primary immunodeficiency disorders with a wide-ranging clinical spectrum. CVID-associated non-infectious morbidity constitutes a major challenge requiring a full understanding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a8e94959a1b2dfea36fa64014e1b28a
http://hdl.handle.net/2445/191646
http://hdl.handle.net/2445/191646
Autor:
Giné Soca, Eva, Cruz, Fátima de la, Jiménez Ubieto, Ana, López Jimenez, Javier, Martín García-Sancho, Alejandro, Terol, M. José, González Barca, Eva, Casanova, María, Fuente, Adolfo de la, Marín Niebla, Ana, Muntañola, Ana, González López, Tomás José, Aymerich Gregorio, Marta, Setoain, Xavier, Cortés Romera, Montserrat, Rotger, Amanda, Rodríguez, Sonia, Medina Herrera, Alejandro, García Sanz, Ramón, Nadeu, Ferran, Beà Bobet, Sílvia M., Campo Güerri, Elias, López Guillermo, Armando, The GELTAMO Group
Publikováno v:
Scientia
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Dipòsit Digital de la UB
Universidad de Barcelona
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
[Puropose]: The need for an individualized management of indolent clinical forms in mantle cell lymphoma (MCL) is increasingly recognized. We hypothesized that a tailored treatment with ibrutinib in combination with rituximab (IR) could obtain signif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d0b9aaabc06751378a905d8c7a0480f
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02321
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.21.02321
Autor:
Eva, González Barca
Publikováno v:
Dipòsit Digital de la UB
Universidad de Barcelona
Universidad de Barcelona
Diffuse large B-cell lymphoma is an aggressive and biologically heterogeneous disease. R-CHOP is the standard first line therapy and cures more than 60% of patients. Salvage high-dose chemotherapy with autologous stem cell transplant remains the stan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809056d48d4a234ae083eee3b47381f4
http://hdl.handle.net/2445/188906
http://hdl.handle.net/2445/188906